CRISPR Therapeutics (NASDAQ:CRSP) Announces Quarterly Earnings Results, Beats Estimates By $0.26 EPS
CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) announced its quarterly earnings results on Monday. The company reported ($0.94) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.20) by $0.26, FiscalAI reports. The company had revenue of $10.18 million for the quarter, compared to the consensus estimate of $7.45 million. CRISPR Therapeutics […]
3 Aug 20:40 · The Markets Daily